PE20030538A1 - Derivados de gabusectin, procedimientos para su preparacion y su uso - Google Patents

Derivados de gabusectin, procedimientos para su preparacion y su uso

Info

Publication number
PE20030538A1
PE20030538A1 PE2002001049A PE2002001049A PE20030538A1 PE 20030538 A1 PE20030538 A1 PE 20030538A1 PE 2002001049 A PE2002001049 A PE 2002001049A PE 2002001049 A PE2002001049 A PE 2002001049A PE 20030538 A1 PE20030538 A1 PE 20030538A1
Authority
PE
Peru
Prior art keywords
derivatives
gabusectin
alkenyl
alkyl
preparation
Prior art date
Application number
PE2002001049A
Other languages
English (en)
Inventor
Luigi Toti
Matthias Schiell
Astrid Markus-Erb
Martin Knauf
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of PE20030538A1 publication Critical patent/PE20030538A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/44—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Abstract

SE REFIERE A DERIVADOS DE GABUSECTIN DE FORMULA I DONDE R1, R2, R3 SON H, ALQUILO, OH, =O, O-ALQUILO, O-ALQUENILO, ARILO, NH-ALQUILO, NH-ALQUENILO, NH2, HALOGENO; R4 ES ALQUILO, ALQUENILO; R5 ES H, METILO; X, X2, X3, X4, X5 SON O, NH, N-ALQUILO, N-ALQUENILO, N-ALQUINILO, N-ACILO, N-ARILO, N-O-R, S. LOS COMPUESTOS SE CARACTERIZAN POR EL ESPECTRO DE MASA ESI, FAB QUE SE ENCUENTRAN ENTRE 0,70 A 203,37. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA ELABORAR POR FERMENTACION CON EL MICROORGANISMO ST 003236
PE2002001049A 2001-11-21 2002-10-24 Derivados de gabusectin, procedimientos para su preparacion y su uso PE20030538A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10156906A DE10156906A1 (de) 2001-11-21 2001-11-21 Gabusectin-Derivate, Verfahren zu deren Herstellung und deren Verwendung

Publications (1)

Publication Number Publication Date
PE20030538A1 true PE20030538A1 (es) 2003-08-01

Family

ID=7706333

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2002001049A PE20030538A1 (es) 2001-11-21 2002-10-24 Derivados de gabusectin, procedimientos para su preparacion y su uso

Country Status (10)

Country Link
EP (1) EP1448522B1 (es)
JP (1) JP2006501132A (es)
AT (1) ATE421951T1 (es)
AU (1) AU2002366191B2 (es)
CA (1) CA2467251A1 (es)
DE (2) DE10156906A1 (es)
IL (1) IL162069A0 (es)
MX (1) MXPA04004537A (es)
PE (1) PE20030538A1 (es)
WO (1) WO2003043984A1 (es)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6476062B2 (en) * 2000-03-30 2002-11-05 Schering Corporation Chemokine receptor antagonists
DE10060810A1 (de) * 2000-12-07 2002-06-20 Aventis Pharma Gmbh Coniosetin und Derivate davon, Verfahren zur Herstellung und Verwendung derselben

Also Published As

Publication number Publication date
IL162069A0 (en) 2005-11-20
DE10156906A1 (de) 2003-05-28
ATE421951T1 (de) 2009-02-15
EP1448522A1 (de) 2004-08-25
CA2467251A1 (en) 2003-05-30
EP1448522B1 (de) 2009-01-28
WO2003043984A1 (de) 2003-05-30
MXPA04004537A (es) 2004-08-11
DE50213257D1 (de) 2009-03-19
JP2006501132A (ja) 2006-01-12
AU2002366191B2 (en) 2008-01-31
AU2002366191A1 (en) 2003-06-10

Similar Documents

Publication Publication Date Title
BE2017C018I2 (es)
NL350075I2 (es)
TW200510431A (en) Quinazoline derivatives
MXPA04001685A (es) Derivados de sulfonilamino empleados como herbicida.
WO2003050087A3 (en) Novel herbicides
MXPA02012033A (es) Derivados de 2-aminocarbonil-9h-purina.
YU55602A (sh) Amino derivati dihidro-1,3,5-triazina i njihova terapeutska primena
MXPA03008754A (es) Derivados de piridina fundidos para utilizarse como agonistas receptores vaniloide para tratar dolor.
GEP20074148B (en) Pyrrolo-triazine aniline compounds useful as kinase inhibitors
MXPA05012247A (es) Derivados de bencimidazol nuevos.
MXPA03008215A (es) Inhibidores de integrina alfa v beta 6.
NZ334954A (en) Substituted heterocycles as anti-tumor agents
NO20075617L (no) 4-fenyl-5-okso-1,4,5,6,7,8-heksahydrokinolinderivater for behandling av infertilitet
MXPA04002495A (es) Compuestos de imidazopiridin como moduladores del receptor 5-ht4.
MY139612A (en) Benzoxazine derivatives as 5-th6 modulators and uses thereof
TW200512201A (en) New heterocyclic amides
MY136824A (en) Substituted benzoxazinones and uses thereof
MXPA04006041A (es) Antivirales de piridoquinoxalina.
IL166439A0 (en) Endiandric acid derivatives as c-maf inhibitors for using against asthma
GEP20084306B (en) Antibacterial indolone oxazolidinones, intermediates for their preparation and pharmaceutical compositions containing them
DE60112960D1 (de) Kondensierte pyridoindolderivate
RS20050506A (en) Novel herbicides
CA2412596A1 (en) Cyclic gmp-specific phosphodiesterase inhibitors
NO20022123L (no) Osoksazolderivater for anvendelse som inhibitorer for fosfodiesterase VII
MXPA03004023A (es) Compuestos quimicos.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal